Abbott, announced data from late-breaking presentations showing the impact of its minimally invasive heart devices in treating mitral and tricuspid valve disease. Data include findings...
Abbott announces the launch of its TactiFlex, Sensor Enabled ablation catheter, the world's first ablation catheter with a flexible tip and contact force technology....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back...
Abbott announced late-breaking data for MitraClip, the leading therapy to treat leaky valves in people with mitral regurgitation (MR), that demonstrate long-term benefits of...
Abbott announced late-breaking data for its next-generation Navitor transcatheter aortic valve implantation system. Results from the study supported Navitor's recent U.S. Food and Drug...
